Sbd

P112 - Revisão Sistemática E Metanálise Dos Desfechos CV E Renais Dos ISGLT2 - Euler Manenti

Informações:

Sinopse

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018 Nov 9.